Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

Norathyriol suppresses transformation in JB6 P+ cells by the inhibition of Akt.

Li J, Li X, He Z, Zhou K.

J Cancer Res Ther. 2012 Oct-Dec;8(4):561-4. doi: 10.4103/0973-1482.106537.

PMID:
23361275
[PubMed - indexed for MEDLINE]
2.

Inhibition of tetrandrine on epidermal growth factor-induced cell transformation and its signal transduction.

Nomura M, Yamazaki R, Takaya M, Kikuchi M, Takahashi-Nishioka T, Akiyama K, Akiyama N, Moritani S, Kobayashi S.

Anticancer Res. 2007 Sep-Oct;27(5A):3187-93.

PMID:
17970060
[PubMed - indexed for MEDLINE]
Free Article
3.

5'-Nitro-indirubinoxime inhibits epidermal growth factor- and phorbol ester-induced AP-1 activity and cell transformation through inhibition of phosphorylation of Pin1.

Khanal P, Choi HK, Namgoong GM, Ahn SG, Yoon JH, Sohn H, Choi HS.

Mol Carcinog. 2011 Dec;50(12):961-71. doi: 10.1002/mc.20761. Epub 2011 Mar 11.

PMID:
21400615
[PubMed - indexed for MEDLINE]
4.

Quercetin-3-methyl ether suppresses proliferation of mouse epidermal JB6 P+ cells by targeting ERKs.

Li J, Mottamal M, Li H, Liu K, Zhu F, Cho YY, Sosa CP, Zhou K, Bowden GT, Bode AM, Dong Z.

Carcinogenesis. 2012 Feb;33(2):459-65. doi: 10.1093/carcin/bgr281. Epub 2011 Dec 1.

PMID:
22139441
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

The role of glycogen synthase kinase 3beta in the transformation of epidermal cells.

Ma C, Wang J, Gao Y, Gao TW, Chen G, Bower KA, Odetallah M, Ding M, Ke Z, Luo J.

Cancer Res. 2007 Aug 15;67(16):7756-64.

PMID:
17699780
[PubMed - indexed for MEDLINE]
Free Article
6.

p38 Mitogen-activated protein kinase regulation of JB6 Cl41 cell transformation promoted by epidermal growth factor.

He Z, Cho YY, Liu G, Ma WY, Bode AM, Dong Z.

J Biol Chem. 2003 Jul 18;278(29):26435-42. Epub 2003 May 13.

PMID:
12748197
[PubMed - indexed for MEDLINE]
Free Article
7.

Norathyriol suppresses skin cancers induced by solar ultraviolet radiation by targeting ERK kinases.

Li J, Malakhova M, Mottamal M, Reddy K, Kurinov I, Carper A, Langfald A, Oi N, Kim MO, Zhu F, Sosa CP, Zhou K, Bode AM, Dong Z.

Cancer Res. 2012 Jan 1;72(1):260-70. doi: 10.1158/0008-5472.CAN-11-2596. Epub 2011 Nov 14.

PMID:
22084399
[PubMed - indexed for MEDLINE]
Free PMC Article
8.
9.

Inhibition of epidermal growth factor-induced cell transformation by tannins.

Nomura M, Tsukada H, Ichimatsu D, Ito H, Yoshida T, Miyamoto K.

Phytochemistry. 2005 Sep;66(17):2038-46.

PMID:
16153407
[PubMed - indexed for MEDLINE]
10.

Mitogen- and stress-activated kinase 1-mediated histone H3 phosphorylation is crucial for cell transformation.

Kim HG, Lee KW, Cho YY, Kang NJ, Oh SM, Bode AM, Dong Z.

Cancer Res. 2008 Apr 1;68(7):2538-47. doi: 10.1158/0008-5472.CAN-07-6597.

PMID:
18381464
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Phosphoinositol 3-kinase, a novel target molecule for the inhibitory effects of juglone on TPA-induced cell transformation.

Chae JI, Cho JH, Kim DJ, Lee KA, Cho MK, Nam HS, Woo KM, Lee SH, Shim JH.

Int J Mol Med. 2012 Jul;30(1):8-14. doi: 10.3892/ijmm.2012.969. Epub 2012 Apr 10.

PMID:
22505246
[PubMed - indexed for MEDLINE]
12.

Omega 3 but not omega 6 fatty acids inhibit AP-1 activity and cell transformation in JB6 cells.

Liu G, Bibus DM, Bode AM, Ma WY, Holman RT, Dong Z.

Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7510-5.

PMID:
11416221
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Inhibition of epidermal growth factor-induced cell transformation and Akt activation by caffeine.

Nomura M, Ichimatsu D, Moritani S, Koyama I, Dong Z, Yokogawa K, Miyamoto K.

Mol Carcinog. 2005 Sep;44(1):67-76.

PMID:
16044420
[PubMed - indexed for MEDLINE]
14.

Raf and MEK protein kinases are direct molecular targets for the chemopreventive effect of quercetin, a major flavonol in red wine.

Lee KW, Kang NJ, Heo YS, Rogozin EA, Pugliese A, Hwang MK, Bowden GT, Bode AM, Lee HJ, Dong Z.

Cancer Res. 2008 Feb 1;68(3):946-55. doi: 10.1158/0008-5472.CAN-07-3140.

PMID:
18245498
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

bcl-2 enhancement of malignant transformation in mouse epidermal JB6 cells.

Amstad PA, Liu H, Ichimiya M, Chang S, Berezesky IK, Trump BF.

Mol Carcinog. 1997 Oct;20(2):231-9.

PMID:
9364213
[PubMed - indexed for MEDLINE]
16.

Two novel glycosides from the fruits of Morinda citrifolia (noni) inhibit AP-1 transactivation and cell transformation in the mouse epidermal JB6 cell line.

Liu G, Bode A, Ma WY, Sang S, Ho CT, Dong Z.

Cancer Res. 2001 Aug 1;61(15):5749-56.

PMID:
11479211
[PubMed - indexed for MEDLINE]
Free Article
17.

Shortage of mitogen-activated protein kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells.

Huang C, Ma WY, Young MR, Colburn N, Dong Z.

Proc Natl Acad Sci U S A. 1998 Jan 6;95(1):156-61.

PMID:
9419345
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Involvement of the Akt/mTOR pathway on EGF-induced cell transformation.

Nomura M, He Z, Koyama I, Ma WY, Miyamoto K, Dong Z.

Mol Carcinog. 2003 Sep;38(1):25-32.

PMID:
12949840
[PubMed - indexed for MEDLINE]
19.

Inhibitory effects of a new 1H-pyrrolo[3,2-c]pyridine derivative, KIST101029, on activator protein-1 activity and neoplastic cell transformation induced by insulin-like growth factor-1.

Yun HJ, Kim G, Khanal P, Kim K, Oh CH, Choi HK, Sohn H, Choi HS.

Biol Pharm Bull. 2013;36(9):1466-73. Epub 2013 Jun 10.

PMID:
23748899
[PubMed - indexed for MEDLINE]
Free Article
20.

Equol, a metabolite of the soybean isoflavone daidzein, inhibits neoplastic cell transformation by targeting the MEK/ERK/p90RSK/activator protein-1 pathway.

Kang NJ, Lee KW, Rogozin EA, Cho YY, Heo YS, Bode AM, Lee HJ, Dong Z.

J Biol Chem. 2007 Nov 9;282(45):32856-66. Epub 2007 Aug 27.

PMID:
17724030
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk